Who has invested in Dizal Pharma?

Lilly Asia Ventures, SANY Group are named among the investors backing Dizal Pharma.

Dizal Pharma Funding: $100M Raised, Series A (2020)

Dizal Pharma funding overview

Dizal Pharma is based in Shanghai, China. Dizal Pharma has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2020. The round record for Dizal Pharma runs through 2020; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, SANY Group. 2 distinct backers are named across the disclosed rounds.

Dizal Pharma at a glance

Total raised: $100M
Latest round: Series A
Latest round date: August 2020
Headquarters: Shanghai, China
Notable investors: Lilly Asia Ventures, SANY Group

Frequently asked about Dizal Pharma funding

How much has Dizal Pharma raised?: Dizal Pharma has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Dizal Pharma?: Lilly Asia Ventures, SANY Group are named among the investors backing Dizal Pharma.
What was the latest Dizal Pharma funding round?: The most recent disclosed round is a Series A, announced in August 2020.
Where is Dizal Pharma based?: Dizal Pharma is based in Shanghai, China.
When did Dizal Pharma last raise?: The last disclosed Dizal Pharma round closed in August 2020 at Series A.

Every Dizal Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.

Dizal Pharma Funding: $100M Raised, Series A (2020)

Dizal Pharma funding overview

Dizal Pharma at a glance

Frequently asked about Dizal Pharma funding

Companies related to Dizal Pharma (36)

Browse related funding lists (6)